Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Skeggs

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Environmental Mutagenesis|January 1, 1979
Mutagenic evaluation of nitroparaffins in the Salmonella typhimurium/mammalian-microsome test and the micronucleus testM Hite, H Skeggs
Mutation Research|November 1, 1976
Mutagenic evaluation of ronidazoleM Hite, H Skeggs, J Noveroske, et al.
Journal of Pharmaceutical Sciences|July 1, 1983
Identification of in vitro (rat liver postmitochondrial S9 fraction) metabolites of the antiprotozoal agent 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole W J Vandenheuvel, H Skeggs, B H Arison, et al.
European Journal of Clinical Pharmacology|March 22, 1976
Comparative clinical pharmacology of intravenous cefoxitin and cephalothinP F Sonneville, R R Kartodirdjo, H Skeggs, et al.
European Journal of Clinical Pharmacology|December 2, 1977
Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitinP F Sonneville, K S Albert, H Skeggs, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1974
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothinC S Goodwin, E B Raftery, A D Goldberg, et al.
Reviews of Infectious Diseases|January 1, 1979
Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporinsJ J Schrogie, J D Rogers, K C Yeh, et al.
Journal of Pharmaceutical Sciences|September 1, 1979
Urinary metabolites of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole in the dogW J Vandenheuvel, B H Arison, T W Miller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Environmental Mutagenesis|January 1, 1979
Mutagenic evaluation of nitroparaffins in the Salmonella typhimurium/mammalian-microsome test and the micronucleus testM Hite, H Skeggs
Mutation Research|November 1, 1976
Mutagenic evaluation of ronidazoleM Hite, H Skeggs, J Noveroske, et al.
Journal of Pharmaceutical Sciences|July 1, 1983
Identification of in vitro (rat liver postmitochondrial S9 fraction) metabolites of the antiprotozoal agent 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole W J Vandenheuvel, H Skeggs, B H Arison, et al.
European Journal of Clinical Pharmacology|March 22, 1976
Comparative clinical pharmacology of intravenous cefoxitin and cephalothinP F Sonneville, R R Kartodirdjo, H Skeggs, et al.
European Journal of Clinical Pharmacology|December 2, 1977
Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitinP F Sonneville, K S Albert, H Skeggs, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1974
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothinC S Goodwin, E B Raftery, A D Goldberg, et al.
Reviews of Infectious Diseases|January 1, 1979
Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporinsJ J Schrogie, J D Rogers, K C Yeh, et al.
Journal of Pharmaceutical Sciences|September 1, 1979
Urinary metabolites of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole in the dogW J Vandenheuvel, B H Arison, T W Miller, et al.
Pageof 1